BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6815072)

  • 1. Human Ia molecules carrying DC1 or BR4X7 determinants are not homologous to murine I-E molecules.
    Tosi R; Tanigaki N; Sorrentino R; van Mourik P; Ivanyi P
    Immunogenetics; 1982; 16(3):187-99. PubMed ID: 6815072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfingerprinting analysis of human Ia molecules favours a three loci model.
    Sorrentino R; Corte G; Calabi F; Tanigaki N; Tosi R
    Mol Immunol; 1983 Mar; 20(3):333-43. PubMed ID: 6191204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
    Shaw S; Ziegler A; DeMars R
    Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological cross-reactivity of murine A.TH anti-A.TL antibody (anti-l-Ek antibody) with La-like molecules of human antigen-presenting cells.
    Okubo Y; Kusama S; Yamashita Y; Kitazawa K; Nagasaka M; Yano A
    Cell Immunol; 1983 Feb; 76(1):1-9. PubMed ID: 6187482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities.
    Tanigaki N; Tosi R
    Immunol Rev; 1982; 66():5-37. PubMed ID: 6182090
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits.
    Quaranta V; Tanigaki N; Ferrone S
    Immunogenetics; 1981; 12(1-2):175-82. PubMed ID: 6162791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species cross-reactive Ia determinants: detection with a monoclonal antibody to human Ia of a murine Ia. 7 epitope.
    Falk JA; Addis JB; Letarte M
    Hum Immunol; 1983 Jun; 7(2):79-88. PubMed ID: 6190791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular specificity of a monoclonal anti-Ik alloantibody identifying a highly conserved determinant on mouse I-A, I-E and human DR antigens.
    Pierres M; Lafuse WP; Dosseto M; Devaux C; Birnbaum DZ; David CS
    Tissue Antigens; 1982 Sep; 20(3):208-20. PubMed ID: 6182640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus.
    Tanigaki N; Tosi R; Pressman D; Ferrara GB
    Immunogenetics; 1980; 10(2):151-67. PubMed ID: 6932390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mouse anti-I region antiserum and complement on human mononuclear cell response to concanavalin A.
    Campbell DA; Oehler JR; Tsai CT; LoBuglio AF; Niederhuber JE
    J Immunol; 1982 May; 128(5):2057-62. PubMed ID: 6977582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of specific binding of soluble Ia by I-region restricted alloactivated T cells.
    Elliott BE; Palfree RG
    J Immunol Methods; 1984 Aug; 72(1):11-28. PubMed ID: 6431007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
    Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
    J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on human Ia supertypic specificities by complement fixation on PHA blasts. I. Serological properties of DC1 specificity.
    Guilherme L; Colombani M; Sansonetti N; Degos L; Colombani J
    Rev Fr Transfus Immunohematol; 1983 Sep; 26(4):379-94. PubMed ID: 6197740
    [No Abstract]   [Full Text] [Related]  

  • 15. Some fixation reagents reduce or abolish the detectability of Ia-antigen and HLA-DR on cells.
    Walker WS; Beelen RH; Buckley PJ; Melvin SL; Yen SE
    J Immunol Methods; 1984 Feb; 67(1):89-99. PubMed ID: 6421936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human HLA-DR antigens are encoded by multiple beta-chain loci.
    Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
    J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR.
    Hirschberg H; Braathen LR; Thorsby E
    Immunol Rev; 1982; 66():57-77. PubMed ID: 6215331
    [No Abstract]   [Full Text] [Related]  

  • 19. Shared idiotope on monoclonal anti-Ia.7 antibodies reactive with determinants in a structural domain of the I-E molecules.
    Devaux C; Labit C; Marchetto S; Pierres M
    J Immunol; 1984 Mar; 132(3):1353-60. PubMed ID: 6198390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants.
    Corte G; Calabi F; Damiani G; Bargellesi A; Tosi R; Sorrentino R
    Nature; 1981 Jul; 292(5821):357-60. PubMed ID: 6166865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.